Blood monitoring for bile duct cancer treatment and outlook
Part of Cancer clinical trials.
This trial uses a simple blood test to track how well bile duct cancer responds to treatment and to predict outcomes. It may help doctors make better decisions about surgery and other therapies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are suspected or diagnosed with bile duct cancer (cholangiocarcinoma).
- You are being evaluated for surgery that aims to cure the cancer.
- You are 18 years or older.
- Your cancer has not spread to other organs (except possibly lymph nodes).
- You have not had surgery to remove your current bile duct cancer already.
- You have not had chemotherapy, radiation, or any cancer treatment for this bile duct cancer before this blood test.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new blood test to help find cholangiocarcinoma (bile duct cancer) earlier and more easily. If you are scheduled for surgery for this cancer, this test may help confirm the diagnosis without more invasive procedures.
This study tracks how bile duct and liver cancers change during treatment, to help doctors find the best therapies for patients. It is for people who are newly diagnosed or starting a new treatment.
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
This trial tests whether a sample of bile (a fluid produced by your liver) can help doctors diagnose bile duct cancer more accurately. If you have a narrowing in your bile duct and need a procedure to take a tissue sample, you may be able to participate.
This trial tests a chemotherapy approach after surgery for bile duct or gallbladder cancers. The goal is to see if giving chemotherapy based on a detailed analysis of your tumor (called 3D-PTA) helps prevent the cancer from coming back.
This study is collecting information and blood samples from people with biliary tract cancer to understand how certain markers and quality-of-life measures relate to treatment outcomes. The findings may help improve future care and support.
Hear when a new Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.